These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29210637)

  • 1. Metallopharmaceuticals in Therapy - A New Horizon for Scientific Research.
    Chylewska A; Biedulska M; Sumczynski P; Makowski M
    Curr Med Chem; 2018; 25(15):1729-1791. PubMed ID: 29210637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
    Mahapatra DK; Bharti SK; Asati V; Singh SK
    Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Metal Ions Complexes and their Ligands in Medicine, Pharmacy and Cosmetology.
    Budzisz E
    Curr Med Chem; 2019; 26(4):578-579. PubMed ID: 30968767
    [No Abstract]   [Full Text] [Related]  

  • 6. Ag+ Complexes as Potential Therapeutic Agents in Medicine and Pharmacy.
    Hecel A; Kolkowska P; Krzywoszynska K; Szebesczyk A; Rowinska-Zyrek M; Kozlowski H
    Curr Med Chem; 2019; 26(4):624-647. PubMed ID: 28933286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review: Pharmacological aspects of metal based 1,2,4-triazole derived Schiff bases.
    Zafar W; Sumrra SH; Chohan ZH
    Eur J Med Chem; 2021 Oct; 222():113602. PubMed ID: 34139626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective: the potential of pyrazole-based compounds in medicine.
    Keter FK; Darkwa J
    Biometals; 2012 Feb; 25(1):9-21. PubMed ID: 22002344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasing the DNA fragments through β-diketimine framed Knoevenagel condensed Cu(II) and Zn(II) complexes--an in vitro and in vivo approach.
    Raman N; Pravin N
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():867-82. PubMed ID: 24161850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Next Generation of Anticancer Metallopharmaceuticals: Cancer Stem Cell-Active Inorganics.
    Laws K; Suntharalingam K
    Chembiochem; 2018 Nov; 19(21):2246-2253. PubMed ID: 30109911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal complexes in medicine and pharmacy - the past and the present II.
    Habala L; Valentová J
    Ceska Slov Farm; 2020; 69(1):3-16. PubMed ID: 32460505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
    Abid M; Shamsi F; Azam A
    Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoselenium transition metal complexes as promising candidates in medicine area.
    Kostić M; Marjanović J; Divac V
    J Biol Inorg Chem; 2024 Sep; 29(6):555-571. PubMed ID: 39123093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminophosphonate metal complexes of biomedical potential.
    Tušek-Božić LJ
    Curr Med Chem; 2013; 20(16):2096-117. PubMed ID: 23432587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recently Reported Biological Activities and Action Targets of Pt(II)- and Cu(II)-Based Complexes.
    Maciel-Flores CE; Lozano-Alvarez JA; Bivián-Castro EY
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential photoactivated metallopharmaceuticals: from active molecules to supported drugs.
    Crespy D; Landfester K; Schubert US; Schiller A
    Chem Commun (Camb); 2010 Sep; 46(36):6651-62. PubMed ID: 20717579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of coumarin bearing metal complexes: Where are we headed?
    Balcıoğlu S; Olgun Karataş M; Ateş B; Alıcı B; Özdemir İ
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126805. PubMed ID: 31753700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum.
    Gaynor D; Griffith DM
    Dalton Trans; 2012 Nov; 41(43):13239-57. PubMed ID: 22930130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal-Drug Synergism in Metallodrug Design.
    Sumithaa C; Ganeshpandian M
    Mol Pharm; 2023 Mar; 20(3):1453-1479. PubMed ID: 36802711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.